ARTHROPLASTY
Perioperative administration of celecoxib reduces opioid consumption
Arthroscopy. 2006 Jun;22(6):635-42.166 patients with knee meniscus disease who were undergoing ambulatory arthroscopic knee meniscectomy were included in a study to test the effects of preoperatively administered celecoxib compared to a placebo. Patients in the experimental group were administered 400 mg of celecoxib 1 hour before surgery, and 200 mg of celecoxib at their first request post-operation. The control group received placebo at both times. Results collected in the 24 hours after surgery demonstrated that the celecoxib group consumed significantly less opioids than the placebo group, experienced fewer opioid related adverse events, and felt less pain overall.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
